These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25008916)

  • 21. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
    Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms in the α4 integrin of neotropical primates: insights for binding of natural ligands and HIV-1 gp120 to the human α4β7.
    Darc M; Hait SH; Soares EA; Cicala C; Seuanez HN; Machado ES; Arthos JA; Soares MA
    PLoS One; 2011; 6(9):e24461. PubMed ID: 21912696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variability OF HIV-1 V2 env domain for integrin binding: Clinical correlates.
    Fabrizio C; Bavaro DF; Scudeller L; Lepore L; Balena F; Lagioia A; Angarano G; Monno L; Saracino A
    Virology; 2019 Sep; 535():266-271. PubMed ID: 31357165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasticity and Epitope Exposure of the HIV-1 Envelope Trimer.
    Powell RLR; Totrov M; Itri V; Liu X; Fox A; Zolla-Pazner S
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoclonal antibodies to the V2 domain of MN-rgp120: fine mapping of epitopes and inhibition of α4β7 binding.
    Nakamura GR; Fonseca DP; O'Rourke SM; Vollrath AL; Berman PW
    PLoS One; 2012; 7(6):e39045. PubMed ID: 22720026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
    Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
    J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conservancy of the α4β7 integrin mimotope in the V2 domain of HIV type 1 CRF07_BC compared to subtype B' strains in China.
    He X; Mokili JL; Hong K; Chen J; Wei J; Xin R; Song YH; Feng Y; Jia M; Xing H; Shao Y
    AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1127-33. PubMed ID: 21417760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A high mucosal blocking score is associated with HIV protection.
    Girard A; Rallón N; Benito JM; Jospin F; Rodriguez C; Chanut B; Benjelloun F; Del Romero J; Verrier B; Lucht F; Pin JJ; Genin C; Biasin M; Clerici M; Paul S
    AIDS; 2019 Mar; 33(3):411-423. PubMed ID: 30703069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrin α
    Sivro A; Schuetz A; Sheward D; Joag V; Yegorov S; Liebenberg LJ; Yende-Zuma N; Stalker A; Mwatelah RS; Selhorst P; Garrett N; Samsunder N; Balgobin A; Nawaz F; Cicala C; Arthos J; Fauci AS; Anzala AO; Kimani J; Bagaya BS; Kiwanuka N; Williamson C; Kaul R; Passmore JS; Phanuphak N; Ananworanich J; Ansari A; Abdool Karim Q; Abdool Karim SS; McKinnon LR;
    Sci Transl Med; 2018 Jan; 10(425):. PubMed ID: 29367348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.
    Dennison SM; Anasti KM; Jaeger FH; Stewart SM; Pollara J; Liu P; Kunz EL; Zhang R; Vandergrift N; Permar S; Ferrari G; Tomaras GD; Bonsignori M; Michael NL; Kim JH; Kaewkungwal J; Nitayaphan S; Pitisuttithum P; Rerks-Ngarm S; Liao HX; Haynes BF; Alam SM
    J Virol; 2014 Aug; 88(16):9406-17. PubMed ID: 24920809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and characterization of a bivalent protein boost for future clinical trials: HIV-1 subtypes CR01_AE and B gp120 antigens with a potent adjuvant.
    Wen Y; Trinh HV; Linton CE; Tani C; Norais N; Martinez-Guzman D; Ramesh P; Sun Y; Situ F; Karaca-Griffin S; Hamlin C; Onkar S; Tian S; Hilt S; Malyala P; Lodaya R; Li N; Otten G; Palladino G; Friedrich K; Aggarwal Y; LaBranche C; Duffy R; Shen X; Tomaras GD; Montefiori DC; Fulp W; Gottardo R; Burke B; Ulmer JB; Zolla-Pazner S; Liao HX; Haynes BF; Michael NL; Kim JH; Rao M; O'Connell RJ; Carfi A; Barnett SW
    PLoS One; 2018; 13(4):e0194266. PubMed ID: 29698406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development.
    Rao M; Peachman KK; Kim J; Gao G; Alving CR; Michael NL; Rao VB
    Curr HIV Res; 2013 Jul; 11(5):427-38. PubMed ID: 24191938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional implications of the binding mode of a human conformation-dependent V2 monoclonal antibody against HIV.
    Spurrier B; Sampson J; Gorny MK; Zolla-Pazner S; Kong XP
    J Virol; 2014 Apr; 88(8):4100-12. PubMed ID: 24478429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early infection HIV-1 envelope V1-V2 genotypes do not enhance binding or replication in cells expressing high levels of α4β7 integrin.
    Etemad B; Gonzalez OA; McDonough S; Pena-Cruz V; Sagar M
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):249-53. PubMed ID: 23797693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
    J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational Engineering of HIV-1 Env Based on Mutational Tolerance in the CD4 and PG16 Bound States.
    Heredia JD; Park J; Choi H; Gill KS; Procko E
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30894475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
    Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.